A patient with suspected unstable angina presents with continued chest discomfort and elevated blood pressure despite initial administration of nitroglycerin and supplemental oxygen. What is the most appropriate next step in the management of this patient?

B) Start an intravenous beta-blocker

A) Administer an additional dose of sublingual nitroglycerin

B) Start an intravenous beta-blocker

C) Increase the oxygen flow rate to 4 liters per minute

D) Prepare the patient for immediate transfer to the coronary care unit

A patient with suspected unstable angina is experiencing elevated blood pressure and moderate chest discomfort despite being on nitroglycerin and supplemental oxygen. What would be the most appropriate next step in managing this patient’s condition?

A) Administer a beta-blocker to decrease myocardial oxygen demand.

B) Increase the oxygen flow rate to improve oxygen saturation.

C) Administer a diuretic to reduce fluid overload.

D) Schedule an immediate coronary angiography to assess for blockages.

A patient in the emergency department is experiencing worsening chest pain despite the administration of nitroglycerin and supplemental oxygen. His ECG shows deeper ST-segment depression, and his troponin levels are rising. Which nursing intervention is most appropriate to prioritize at this time?

C) Initiate a continuous infusion of nitroglycerin as ordered

A) Administer an additional dose of nitroglycerin sublingually

B) Prepare for immediate defibrillation

C) Initiate a continuous infusion of nitroglycerin as ordered

D) Encourage the patient to perform deep breathing exercises

A patient in the emergency department is experiencing worsening myocardial ischemia despite receiving nitroglycerin and supplemental oxygen. His vital signs indicate increased blood pressure and heart rate, and he is becoming more diaphoretic and anxious. The ECG shows deeper ST-segment depression, and cardiac biomarkers indicate rising troponin levels. As the nurse, what is the most critical intervention to prioritize at this time to prevent further myocardial injury?

C) Initiate a continuous infusion of nitroglycerin and consider beta-blocker therapy

A) Administer additional doses of sublingual nitroglycerin

B) Prepare for immediate transfer to the coronary care unit (CCU)

C) Initiate a continuous infusion of nitroglycerin and consider beta-blocker therapy

D) Provide emotional support and reassurance to reduce anxiety

A patient in the coronary care unit is experiencing significant chest pain and frequent premature ventricular contractions despite receiving a nitroglycerin infusion. After administering metoprolol to manage his elevated heart rate, what is the next priority nursing intervention to prevent further cardiac instability?

C) Monitor the patient's potassium levels and electrolytes.

A) Increase the oxygen flow rate to improve oxygen saturation.

B) Prepare the patient for immediate cardioversion.

C) Monitor the patient's potassium levels and electrolytes.

D) Administer a higher dose of nitroglycerin to alleviate chest pain.

A patient in the coronary care unit (CCU) with confirmed acute coronary syndrome is experiencing frequent premature ventricular contractions (PVCs) after starting on a nitroglycerin infusion and metoprolol. What is the most appropriate initial nursing action to address these PVCs and prevent further cardiac instability?

B) Assess the patient's electrolyte levels, particularly potassium and magnesium.

A) Increase the nitroglycerin infusion rate to improve coronary blood flow.

B) Assess the patient's electrolyte levels, particularly potassium and magnesium.

C) Administer a scheduled dose of metoprolol to further decrease heart rate.

D) Prepare for immediate cardioversion to address the arrhythmia.

A patient receiving metoprolol and nitroglycerin presents with hypotension, dizziness, and clammy skin. After reducing the nitroglycerin infusion, which action should the nurse prioritize to ensure patient safety?

B) Monitor cardiovascular status and adjust medication dosages as needed

A) Increase the metoprolol dosage to reduce heart rate further

B) Monitor cardiovascular status and adjust medication dosages as needed

C) Administer additional oxygen to address potential hypoxia

D) Reassure the patient and provide anxiolytics to reduce anxiety

A patient receiving metoprolol and nitroglycerin infusions for cardiac management exhibits signs of hypotension, dizziness, and anxiety. The clinical team is considering adjusting the treatment plan. Which nursing intervention is most appropriate to address the patient's current condition?

C) Temporarily reduce the nitroglycerin infusion rate while closely monitoring blood pressure and heart rate.

A) Increase the metoprolol infusion rate to manage the heart rate more effectively.

B) Initiate a rapid saline bolus to immediately raise blood pressure and improve perfusion.

C) Temporarily reduce the nitroglycerin infusion rate while closely monitoring blood pressure and heart rate.

D) Administer an anxiolytic medication to relieve the patient's anxiety and prevent further cardiac workload.

A patient with hypotension, elevated lactate levels, and metabolic acidosis is being monitored following adjustments to their treatment plan. The patient now presents with dizziness, mild confusion, and frequent premature ventricular contractions. What is the most appropriate immediate nursing intervention?

B) Administer a fluid bolus to improve perfusion

A) Increase the oxygen flow rate to improve oxygenation

B) Administer a fluid bolus to improve perfusion

C) Initiate a norepinephrine infusion to increase blood pressure

D) Increase the nitroglycerin infusion to reduce cardiac workload

A patient with a history of cardiac issues presents with persistent hypotension despite reduced nitroglycerin infusion. The patient exhibits signs of peripheral vasoconstriction, mild confusion, and elevated lactate levels. The ABG shows a metabolic acidosis with partial respiratory compensation. Which nursing intervention should be prioritized to address the current clinical situation?

B) Administer a fluid bolus to improve intravascular volume and perfusion.

A) Increase the oxygen flow rate to 4 liters per minute via nasal cannula.

B) Administer a fluid bolus to improve intravascular volume and perfusion.

C) Initiate an antiarrhythmic medication to control ventricular ectopy.

D) Prepare for immediate intubation to address the elevated respiratory rate.

chest pain - Nursing Case Study

Pathophysiology

• Primary mechanism: Myocardial ischemia occurs when there is an imbalance between oxygen supply and demand in the heart muscle, often due to coronary artery disease, leading to reduced blood flow and oxygen deprivation, causing chest pain (angina).

• Secondary mechanism: Gastroesophageal reflux disease (GERD) can cause chest pain when stomach acid irritates the esophagus, resulting in pain that may mimic cardiac-related chest discomfort, usually worsening when lying down or after meals.

• Key complication: If myocardial ischemia progresses without intervention, it can lead to myocardial infarction (heart attack), where prolonged oxygen deprivation causes irreversible heart muscle damage, significantly increasing morbidity and mortality risks.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension, high cholesterol, smoking history (20 pack-years)

• Current medications: Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain

• Key symptoms: Moderate chest pain radiating to left arm, shortness of breath, dizziness, nausea

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

As the nursing team continues to monitor the patient, new diagnostic results are received that provide further insight into his condition. An electrocardiogram (ECG) reveals ST-segment depression in the anterior leads, indicative of myocardial ischemia. Additionally, initial laboratory results show elevated cardiac biomarkers, with troponin levels slightly above the normal range, suggesting myocardial injury. The patient's lipid profile remains concerning, with LDL cholesterol at 160 mg/dL, despite being on atorvastatin. These findings, combined with his history and symptoms, strengthen the suspicion of unstable angina, a precursor to myocardial infarction if not promptly managed.

In response to these diagnostic findings, the healthcare team initiates several interventions aimed at stabilizing the patient. Nitroglycerin is administered sublingually to alleviate chest pain by dilating coronary arteries, improving oxygen delivery to the heart muscle. The patient is placed on supplemental oxygen to address hypoxemia, with saturation improving to 95% on 2 liters via nasal cannula. Despite these measures, the patient continues to report moderate chest discomfort, and his blood pressure remains elevated at 148/92 mmHg. This prompts consideration of additional antihypertensive therapy to manage his blood pressure more effectively.

With these developments, the clinical team must now decide on the next steps, including possible admission to a coronary care unit for closer monitoring and further interventions. The potential for progression to myocardial infarction remains a significant concern, requiring vigilant observation for changes in the patient's clinical status. This situation underscores the importance of timely intervention and continuous reassessment to prevent deterioration and ensure optimal outcomes for the patient.

Section 2

As the patient continues to be monitored in the emergency department, the clinical team notes a change in his status. Despite the administration of nitroglycerin and supplemental oxygen, the patient's chest discomfort persists and begins to intensify. His vital signs indicate a concerning trend: blood pressure has risen to 160/98 mmHg, and heart rate has increased to 112 beats per minute, suggesting a heightened sympathetic response. Additionally, the patient appears increasingly diaphoretic and anxious, further raising the suspicion of escalating myocardial stress.

In response to these developments, the healthcare team orders a repeat ECG, which now shows deeper ST-segment depression compared to the initial results, reinforcing the concern for worsening myocardial ischemia. A repeat set of cardiac biomarkers reveals a further rise in troponin levels, indicating ongoing myocardial injury. These findings suggest that the patient's condition is progressing towards a more severe ischemic event, potentially an evolving myocardial infarction.

Recognizing the urgency, the medical team decides to escalate care by preparing for potential transfer to the coronary care unit (CCU) for more intensive monitoring and management. They also initiate a continuous infusion of nitroglycerin to more aggressively target the patient's ischemic pain and consider adding a beta-blocker to mitigate the elevated heart rate and blood pressure. The nursing team remains vigilant, closely monitoring for any signs of complications such as arrhythmias or hemodynamic instability, while ensuring that the patient is kept informed and reassured throughout the process. This proactive approach aims to prevent further deterioration and optimize the patient's clinical outcome.

Section 3

As the patient is transferred to the coronary care unit (CCU), the nursing team conducts a thorough assessment to capture any changes in his condition. Upon arrival, the patient is still experiencing significant chest pain, now rated at 8 out of 10, and his anxiety remains evident. His vital signs are re-evaluated: blood pressure is 158/95 mmHg, heart rate is 110 beats per minute, respiratory rate has increased to 24 breaths per minute, and oxygen saturation is slightly decreased at 92% on 2 liters per minute of oxygen via nasal cannula. The patient's skin is clammy and cool to the touch, and he reports feeling dizzy and lightheaded.

In light of these findings, the clinical team reviews the patient's recent ECG, which continues to show deepening ST-segment depression, and discusses the latest cardiac biomarker results, which reveal a further increase in troponin levels. This progression confirms the ongoing myocardial injury and heightens the concern for an acute coronary syndrome. The team decides to continue the nitroglycerin infusion but notes that despite this, the patient's chest pain has not significantly improved. Consequently, the decision is made to introduce a beta-blocker, specifically metoprolol, to address the elevated heart rate and help reduce myocardial oxygen demand.

During this critical period, the nursing staff remains attentive to potential complications such as the development of arrhythmias. Shortly after the interventions are adjusted, the patient begins to exhibit frequent premature ventricular contractions, indicating increased myocardial irritability. The team must rapidly assess the need for further antiarrhythmic treatment and consider adjustments in the patient's care plan to prevent the escalation of cardiac instability. This evolving scenario underscores the importance of continuous monitoring and highlights the dynamic nature of the patient's condition as the healthcare team strives to stabilize him and prevent further cardiac compromise.

Section 4

As the nursing team intensifies their monitoring efforts, they note a troubling change in the patient's status. Approximately 30 minutes after the introduction of metoprolol, the patient's heart rate has decreased to 85 beats per minute, but his blood pressure has dropped to 95/60 mmHg, raising concerns about potential hypotension. Concurrently, the patient reports an increase in dizziness and a sense of impending doom, which could signal further hemodynamic instability. The respiratory rate remains elevated at 22 breaths per minute, and oxygen saturation has slightly improved to 94% on 2 liters per minute via nasal cannula. However, the patient's skin remains clammy, and his level of anxiety has not abated.

In response to these developments, the clinical team reevaluates the therapeutic approach. The recent hypotensive episode necessitates a careful reconsideration of the metoprolol dosage, balancing the need to control the heart rate while ensuring adequate perfusion. The persistence of premature ventricular contractions prompts a discussion about the potential use of amiodarone to stabilize the cardiac rhythm, although the team is mindful of the proarrhythmic risks associated with antiarrhythmic drugs. The patient’s increased dizziness and psychological distress also warrant a reassessment of his overall comfort and the provision of supportive care measures to alleviate anxiety, which could further exacerbate the cardiac workload.

The team decides to temporarily reduce the rate of the nitroglycerin infusion to stabilize the blood pressure, while carefully titrating the metoprolol dose. They also initiate a low-dose amiodarone infusion to address the arrhythmias, with plans for close ECG and hemodynamic monitoring. This adaptive strategy underscores the necessity for vigilant assessment and the ability to swiftly recalibrate treatment plans based on the patient's evolving condition. As the team works collaboratively to optimize the patient's care, they remain cognizant of the need to prevent further complications and prepare for potential emergent interventions should the patient's status continue to decline.

Section 5

As the team implements the adjusted treatment plan, they remain vigilant in their monitoring efforts. Within the next hour, the patient's status shows some troubling changes. The blood pressure, previously stabilized, has further decreased to 88/55 mmHg despite the reduced nitroglycerin infusion. The heart rate maintains at 82 beats per minute, but the patient’s skin remains clammy and cool to the touch, indicating potential peripheral vasoconstriction. The patient continues to report dizziness, now accompanied by a new onset of mild confusion, which raises concerns about cerebral perfusion. Oxygen saturation remains at 94% on 2 liters per minute, but the elevated respiratory rate persists at 24 breaths per minute, suggesting ongoing compensatory mechanisms.

New laboratory results return, revealing an elevated lactate level of 3.2 mmol/L, which may indicate tissue hypoperfusion and developing lactic acidosis. The arterial blood gas analysis shows a pH of 7.32, PaCO2 of 35 mmHg, and HCO3- of 18 mEq/L, consistent with a metabolic acidosis with partial respiratory compensation. These findings corroborate the clinical picture of inadequate perfusion and evolving hemodynamic instability. An ECG performed as part of the ongoing assessment reveals frequent premature ventricular contractions, alongside occasional runs of nonsustained ventricular tachycardia, underscoring the need for continuous cardiac monitoring.

In light of these developments, the clinical team convenes to reassess the treatment priorities. The persistent hypotension, alongside metabolic derangements, necessitates an urgent review of fluid status and potential inotropic support to enhance cardiac output and improve perfusion. The team considers the cautious administration of a fluid bolus and evaluates the need for vasoactive agents, while closely monitoring for pulmonary congestion given the patient's cardiac history. The collaborative approach emphasizes the importance of dynamic clinical reasoning and the capacity to adapt management strategies in response to evolving pathophysiological changes, as they prepare to address any new complications that may arise.